GCT President, Dr. Jeffrey T. Apter, at CNS Summit 2018 in Florida, USA

GCT President, Dr. Jeffrey T. Apter attended CNS Summit 2018 in the The Boca Raton Resort & Club, Florida, USA. It is a great opportunity for pharma and biotech R&D leaders, the top tech companies, investigator sites, service companies, and the regulators from US FDA and EMA to recognize industry trends, lessons and experiences of the year. The Summit is known for its innovative content and format, building the community passionate about shaping the future, with a focus on collaboration, innovation, and technology.

Over the years GCT has gained a great experience of conducting clinical trial in CNS field in United States, Central-Eastern Europe and India. We are closely familiar with key opinion leaders in this therapeutic area, as well as experienced investigative sites and patient organizations and we will gladly apply this knowledge to assure the successful completion of your next planned clinical program.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.